Mssa skin infection treatment
Reading File
Searching the Web
MSSA skin soft tissue infection treatment guidelines 2024 2025
Finding Sources
Searching PubMed
MSSA skin soft tissue infection treatment
Reading File
Reading File
I now have comprehensive information from authoritative sources. Here is a full, structured answer:
MSSA Skin & Soft Tissue Infection (SSTI) Treatment
MSSA remains beta-lactam susceptible, so penicillinase-resistant penicillins and cephalosporins are the backbone of treatment. Management is stratified by infection type (purulent vs. non-purulent) and severity.
1. Non-Purulent Infections (Cellulitis, Erysipelas)
| Severity | Setting | Preferred Agent | Alternative |
|---|---|---|---|
| Mild | Outpatient | Cephalexin 500 mg PO q6h x 5-7 days | Dicloxacillin 500 mg PO q6h |
| Moderate (systemic signs: fever, HR >90, WBC >12k) | Inpatient | Cefazolin IV 1-2 g q8h x 7-10 days | Ceftriaxone IV 1 g q24h |
| Severe (SIRS, organ dysfunction, failing IV therapy) | ICU/ID consult | Nafcillin or oxacillin IV 1-2 g q4-6h | Cefazolin IV; vancomycin if cannot tolerate beta-lactam |
- The addition of MRSA coverage does not improve outcomes for uncomplicated cellulitis - MSSA-targeted therapy is sufficient.
- Clindamycin is no longer recommended for routine purulent SSTIs due to increasing MSSA and CA-MRSA resistance. (Rosen's Emergency Medicine)
2. Purulent Infections (Furuncles, Carbuncles, Abscesses)
- Mild: Incision & drainage (I&D) alone is often sufficient for small uncomplicated abscesses
- Moderate: I&D + send culture, then target therapy once MSSA confirmed:
- Cephalexin 500 mg PO QID x 5-7 days, OR
- Dicloxacillin 500 mg PO QID x 5-7 days
- (If empiric MRSA coverage was started and cultures show MSSA, de-escalate to the above)
- Severe/Hospitalized: Nafcillin or oxacillin IV 1-2 g q4-6h is first-line
3. Specific Infection Types
Impetigo
- Localized: Topical mupirocin (preferred) or retapamulin TID x 5 days
- Widespread: Oral cephalexin x 7 days
- MSSA accounts for the majority of impetigo cases (Harriet Lane Handbook)
Staph Scalded Skin Syndrome (SSSS)
- Nearly all cases are MSSA
- First-line: nafcillin or oxacillin IV (increasing clindamycin resistance noted)
- Consider IV-to-oral step-down once improving
Folliculitis / Minor Furunculosis
- Warm compresses + hygiene measures often sufficient
- For recurrent/moderate: oral cephalexin or dicloxacillin
4. Drug Choices Explained
| Drug | Role | Notes |
|---|---|---|
| Cephalexin (1st-gen cephalosporin) | Oral, mild-moderate | Most commonly used outpatient; beta-lactamase stable |
| Dicloxacillin / Flucloxacillin | Oral, mild-moderate | Penicillinase-resistant; excellent MSSA activity |
| Nafcillin / Oxacillin | IV, severe/invasive | First-line for serious MSSA; superior to vancomycin for MSSA |
| Cefazolin | IV, moderate | Good alternative to nafcillin; easier dosing; effective for skin infections |
| Mupirocin (topical) | Local/impetigo | Nasal decolonization also used to reduce recurrence |
| Vancomycin | Reserve only | NOT recommended for MSSA infections - outcomes inferior to beta-lactams (Red Book 2021) |
5. Why Not Vancomycin for MSSA?
Vancomycin is weakly bactericidal against S. aureus and produces inferior outcomes compared to antistaphylococcal beta-lactams for MSSA infections, including endocarditis and bacteremia. It should only be used when the patient cannot tolerate beta-lactams.
6. Penicillin Allergy
- Type I (anaphylaxis): Use TMP-SMX, doxycycline, or clindamycin (check susceptibility)
- Low-risk allergy (rash only): Can safely receive cephalosporins per 2024 IDSA/allergy guidelines
7. Recurrence Prevention
For recurrent furunculosis/abscess:
- 5-day course of nasal mupirocin + chlorhexidine body washes for patient and household contacts
- Adults: 7-day combination of oral rifampin + doxycycline + nasal mupirocin (Red Book 2021)
Key takeaways:
- Non-purulent cellulitis: oral cephalexin (outpatient) or IV cefazolin (inpatient)
- Purulent abscess: I&D first; add cephalexin/dicloxacillin if MSSA confirmed
- Serious/invasive MSSA: IV nafcillin or oxacillin - never substitute vancomycin
- De-escalate from MRSA empiric therapy to MSSA-targeted beta-lactam once cultures confirm MSSA
Sources: Red Book 2021 (AAP), Rosen's Emergency Medicine, Harriet Lane Handbook 23e, IDSA SSTI Guidelines, April 2024 SSTI Protocol
Doses for antibiotics
Finding Sources
Finding Sources
Reading File
Finding Sources
Excellent - I now have precise doses from Harrison's and Goldman-Cecil. Here is the complete dose reference:
Antibiotic Doses for MSSA Skin Infections
Oral Agents (Outpatient / Mild-Moderate)
| Drug | Adult Dose | Frequency | Duration | Notes |
|---|---|---|---|---|
| Cephalexin | 500 mg | q6h (QID) | 5-7 days | Most common outpatient choice; 1st-gen cephalosporin |
| Dicloxacillin | 500 mg | q6h (QID) | 5-7 days | Take on empty stomach for best absorption |
| Flucloxacillin | 500 mg-1 g | q6h | 5-7 days | Used where available (UK/Australia); same class as dicloxacillin |
| Cefadroxil | 500 mg | q12h | 5-7 days | Twice-daily option; 1st-gen cephalosporin |
| Clindamycin | 300-450 mg | q6-8h | 5-7 days | Only if susceptible; check local resistance |
| Doxycycline | 100 mg | q12h | 5-7 days | Penicillin-allergy alternative |
| TMP-SMX (DS) | 1-2 tablets (160/800 mg) | q12h (BID) | 5-7 days | Penicillin-allergy alternative; verify MSSA susceptibility |
Doses from Harrison's Principles of Internal Medicine 22E (Table 152-3)
IV Agents (Inpatient / Moderate-Severe)
| Drug | Adult Dose | Frequency | Notes |
|---|---|---|---|
| Nafcillin | 2 g IV | q4h | First-line for serious MSSA; superior outcomes vs. vancomycin |
| Oxacillin | 2 g IV | q4h | Equivalent to nafcillin; first-line |
| Cefazolin | 1-2 g IV | q8h | Good alternative; easier dosing, less hepatotoxicity |
| Ceftriaxone | 1 g IV | q24h | Moderate infections; convenient once-daily dosing |
| Clindamycin | 600-900 mg IV | q8h | Adjunct or alternative; not for bacteremia/endocarditis |
| Vancomycin | 15 mg/kg IV | q8-12h | Reserve only - inferior to beta-lactams for MSSA |
| Daptomycin | 6-10 mg/kg IV | q24h | Alternative if beta-lactam intolerant |
IV doses from Goldman-Cecil Medicine and Harrison's 22E
Topical (Localized Impetigo / Decolonization)
| Drug | Formulation | Dose | Duration |
|---|---|---|---|
| Mupirocin 2% | Ointment | Apply TID to lesion | 5 days |
| Mupirocin (nasal) | Nasal ointment | Apply to nares BID | 5 days (decolonization) |
| Retapamulin 1% | Ointment | Apply BID | 5 days |
Pediatric Quick Reference
| Drug | Dose | Notes |
|---|---|---|
| Cephalexin | 25-50 mg/kg/day ÷ q6h (max 4 g/day) | Standard oral choice |
| Dicloxacillin | 25-50 mg/kg/day ÷ q6h | Empty stomach |
| Nafcillin / Oxacillin | 150-200 mg/kg/day ÷ q4-6h IV | Serious/invasive infections |
| Cefazolin | 25-100 mg/kg/day ÷ q8h IV | Moderate-severe, inpatient |
Key Dosing Points
- Dicloxacillin and flucloxacillin must be taken on an empty stomach (30-60 min before food) - food reduces absorption by up to 50%
- Nafcillin/oxacillin are superior to cefazolin for CNS infections (meningitis); for other MSSA infections they are interchangeable
- Nafcillin can cause hepatotoxicity; oxacillin can cause neutropenia - monitor LFTs/CBC on prolonged courses
- Cefazolin has a lower protein binding and less phlebitis than nafcillin - preferred by many for outpatient IV therapy (OPAT)
- Duration for uncomplicated cellulitis is 5 days; extend to 7-14 days if slow to respond
Sources: Harrison's Principles of Internal Medicine 22E, Goldman-Cecil Medicine, Red Book 2021 (AAP)
This is a shared conversation. Sign in to Orris to start your own chat.